BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mirzaei S, Paskeh MDA, Hashemi F, Zabolian A, Hashemi M, Entezari M, Tabari T, Ashrafizadeh M, Raee P, Aghamiri S, Aref AR, Leong HC, Kumar AP, Samarghandian S, Zarrabi A, Hushmandi K. Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies. Life Sci 2021;:119948. [PMID: 34520771 DOI: 10.1016/j.lfs.2021.119948] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu Z, Wang Y, Yan M, Liang Q, Li B, Hou G, Xia T, Lin Z, Xu W. Comprehensive analysis of the endoplasmic reticulum stress-related long non-coding RNA in bladder cancer. Front Oncol 2022;12:951631. [DOI: 10.3389/fonc.2022.951631] [Reference Citation Analysis]
2 Ashrafizadeh M, Zarrabi A, Karimi‐maleh H, Taheriazam A, Mirzaei S, Hashemi M, Hushmandi K, Makvandi P, Nazarzadeh Zare E, Sharifi E, Goel A, Wang L, Ren J, Nuri Ertas Y, Kumar AP, Wang Y, Rabiee N, Sethi G, Ma Z. (Nano)platforms in bladder cancer therapy: Challenges and opportunities. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Motlagh AV, Mahdevar M, Mirzaei S, Entezari M, Hashemi M, Hushmandi K, Peymani M. Introduction of mutant TP53 related genes in metabolic pathways and evaluation their correlation with immune cells, drug resistance and sensitivity. Life Sci 2022;:120650. [PMID: 35667517 DOI: 10.1016/j.lfs.2022.120650] [Reference Citation Analysis]
4 Hirano S, Matsumoto K, Tanaka K, Amano N, Koguchi D, Ikeda M, Shimizu Y, Tsuchiya B, Nagashio R, Sato Y, Iwamura M. DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder Cancer. Cancers 2022;14:2535. [DOI: 10.3390/cancers14102535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mirzaei S, Saghari S, Bassiri F, Raesi R, Zarrabi A, Hushmandi K, Sethi G, Tergaonkar V. NF-κB as a regulator of cancer metastasis and therapy response: A focus on epithelial-mesenchymal transition. J Cell Physiol 2022. [PMID: 35561232 DOI: 10.1002/jcp.30759] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Mahabady MK, Mirzaei S, Saebfar H, Gholami MH, Zabolian A, Hushmandi K, Hashemi F, Tajik F, Hashemi M, Kumar AP, Aref AR, Zarrabi A, Khan H, Hamblin MR, Nuri Ertas Y, Samarghandian S. Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity. J Cell Physiol 2022;237:2309-44. [PMID: 35437787 DOI: 10.1002/jcp.30751] [Reference Citation Analysis]
7 Entezari M, Sadrkhanloo M, Rashidi M, Asnaf SE, Taheriazam A, Hashemi M, Ashrafizadeh M, Zarrabi A, Rabiee N, Hushmandi K, Mirzaei S, Sethi G. Non-coding RNAs and macrophage interaction in tumor progression. Crit Rev Oncol Hematol 2022;:103680. [PMID: 35405273 DOI: 10.1016/j.critrevonc.2022.103680] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
8 Lu YT, Xu T, Iqbal M, Hsieh TC, Luo Z, Liang G, Farnham PJ, Rhie SK, Goldkorn A. FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer. Cancers (Basel) 2022;14:1717. [PMID: 35406487 DOI: 10.3390/cancers14071717] [Reference Citation Analysis]
9 Feng F, Yang J, Chen A, Cui M, Li L. Long non-coding RNA long intergenic non-protein coding RNA 1232 promotes cell proliferation, migration and invasion in bladder cancer via modulating miR-370-5p/PIM3 axis. J Tissue Eng Regen Med 2022. [PMID: 35338769 DOI: 10.1002/term.3291] [Reference Citation Analysis]
10 Ma X, Chen Y, Mo C, Li L, Nong S, Gui C. The role of circRNAs in the regulation of myocardial angiogenesis in coronary heart disease. Microvasc Res 2022;:104362. [PMID: 35337818 DOI: 10.1016/j.mvr.2022.104362] [Reference Citation Analysis]
11 Li M, Che N, Jin Y, Li J, Yang W. CDKN3 Overcomes Bladder Cancer Cisplatin Resistance via LDHA-Dependent Glycolysis Reprogramming. OTT 2022;Volume 15:299-311. [DOI: 10.2147/ott.s358008] [Reference Citation Analysis]
12 Huang CS, Tsai CH, Yu CP, Wu YS, Yee MF, Ho JY, Yu DS. Long Noncoding RNA LINC02470 Sponges MicroRNA-143-3p and Enhances SMAD3-Mediated Epithelial-to-Mesenchymal Transition to Promote the Aggressive Properties of Bladder Cancer. Cancers (Basel) 2022;14:968. [PMID: 35205713 DOI: 10.3390/cancers14040968] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Chen X, Wang P, Ou T, Li J. KLF16 Downregulates the Expression of Tumor Suppressor Gene TGFBR3 to Promote Bladder Cancer Proliferation and Migration. CMAR 2022;Volume 14:465-77. [DOI: 10.2147/cmar.s334521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Li Z, Wang D, Liu Z. Clinical Efficacy and Quality of Life Assessment of Partial Cystectomy and Plasmakinetic Transurethral Resection of Tumor in Bladder Cancer Patients. CMAR 2022;Volume 14:389-98. [DOI: 10.2147/cmar.s346764] [Reference Citation Analysis]
15 Nie Z, Chen M, Gao Y, Huang D, Cao H, Peng Y, Guo N, Zhang S. Regulated Cell Death in Urinary Malignancies. Front Cell Dev Biol 2021;9:789004. [PMID: 34869390 DOI: 10.3389/fcell.2021.789004] [Cited by in F6Publishing: 2] [Reference Citation Analysis]